Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein

Masakazu Ueda, Kyriakos Psarras, Hiromitsu Jinno, Tadashi Ikeda, Kohji Enomoto, Masaki Kitajima, Junichiro Futami, Hidenori Yamada, Masaharu Seno

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recombinant human ribonuclease 1 (RNasel) was chemically linked to recombinant human epidermal growth factor (EGF). The cytotoxicity of this conjugate was assayed using MTT assay. The EGF-RNase conjugate showed dose-dependent cytotoxicity against breast and squamous cell carcinomas overexpressing the EGF receptor (EGFR). The cytotoxicity of the conjugate correlated positively with the level of EGFR expression by each cell line. These results suggest that the EGF-RNase conjugate is a more effective anticancer agent with less immunogenicity and toxicity than conventional chimeric breast cancer toxins.

Original languageEnglish
Pages (from-to)253-255
Number of pages3
JournalBreast Cancer
Volume4
Issue number4
DOIs
Publication statusPublished - 1997 Dec

Fingerprint

Cell Fusion
Ribonucleases
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Breast Neoplasms
Proteins
Antineoplastic Agents
Squamous Cell Carcinoma
Breast
Cell Line

Keywords

  • Breast cancer
  • EGFR
  • Fusion protein
  • RNase
  • Targeting

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Cite this

Ueda, M., Psarras, K., Jinno, H., Ikeda, T., Enomoto, K., Kitajima, M., ... Seno, M. (1997). Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein. Breast Cancer, 4(4), 253-255. https://doi.org/10.1007/BF02966516

Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein. / Ueda, Masakazu; Psarras, Kyriakos; Jinno, Hiromitsu; Ikeda, Tadashi; Enomoto, Kohji; Kitajima, Masaki; Futami, Junichiro; Yamada, Hidenori; Seno, Masaharu.

In: Breast Cancer, Vol. 4, No. 4, 12.1997, p. 253-255.

Research output: Contribution to journalArticle

Ueda, M, Psarras, K, Jinno, H, Ikeda, T, Enomoto, K, Kitajima, M, Futami, J, Yamada, H & Seno, M 1997, 'Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein', Breast Cancer, vol. 4, no. 4, pp. 253-255. https://doi.org/10.1007/BF02966516
Ueda, Masakazu ; Psarras, Kyriakos ; Jinno, Hiromitsu ; Ikeda, Tadashi ; Enomoto, Kohji ; Kitajima, Masaki ; Futami, Junichiro ; Yamada, Hidenori ; Seno, Masaharu. / Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein. In: Breast Cancer. 1997 ; Vol. 4, No. 4. pp. 253-255.
@article{b7e8251913464be480edfa41943303e2,
title = "Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein",
abstract = "Recombinant human ribonuclease 1 (RNasel) was chemically linked to recombinant human epidermal growth factor (EGF). The cytotoxicity of this conjugate was assayed using MTT assay. The EGF-RNase conjugate showed dose-dependent cytotoxicity against breast and squamous cell carcinomas overexpressing the EGF receptor (EGFR). The cytotoxicity of the conjugate correlated positively with the level of EGFR expression by each cell line. These results suggest that the EGF-RNase conjugate is a more effective anticancer agent with less immunogenicity and toxicity than conventional chimeric breast cancer toxins.",
keywords = "Breast cancer, EGFR, Fusion protein, RNase, Targeting",
author = "Masakazu Ueda and Kyriakos Psarras and Hiromitsu Jinno and Tadashi Ikeda and Kohji Enomoto and Masaki Kitajima and Junichiro Futami and Hidenori Yamada and Masaharu Seno",
year = "1997",
month = "12",
doi = "10.1007/BF02966516",
language = "English",
volume = "4",
pages = "253--255",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein

AU - Ueda, Masakazu

AU - Psarras, Kyriakos

AU - Jinno, Hiromitsu

AU - Ikeda, Tadashi

AU - Enomoto, Kohji

AU - Kitajima, Masaki

AU - Futami, Junichiro

AU - Yamada, Hidenori

AU - Seno, Masaharu

PY - 1997/12

Y1 - 1997/12

N2 - Recombinant human ribonuclease 1 (RNasel) was chemically linked to recombinant human epidermal growth factor (EGF). The cytotoxicity of this conjugate was assayed using MTT assay. The EGF-RNase conjugate showed dose-dependent cytotoxicity against breast and squamous cell carcinomas overexpressing the EGF receptor (EGFR). The cytotoxicity of the conjugate correlated positively with the level of EGFR expression by each cell line. These results suggest that the EGF-RNase conjugate is a more effective anticancer agent with less immunogenicity and toxicity than conventional chimeric breast cancer toxins.

AB - Recombinant human ribonuclease 1 (RNasel) was chemically linked to recombinant human epidermal growth factor (EGF). The cytotoxicity of this conjugate was assayed using MTT assay. The EGF-RNase conjugate showed dose-dependent cytotoxicity against breast and squamous cell carcinomas overexpressing the EGF receptor (EGFR). The cytotoxicity of the conjugate correlated positively with the level of EGFR expression by each cell line. These results suggest that the EGF-RNase conjugate is a more effective anticancer agent with less immunogenicity and toxicity than conventional chimeric breast cancer toxins.

KW - Breast cancer

KW - EGFR

KW - Fusion protein

KW - RNase

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=0001620356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0001620356&partnerID=8YFLogxK

U2 - 10.1007/BF02966516

DO - 10.1007/BF02966516

M3 - Article

AN - SCOPUS:0001620356

VL - 4

SP - 253

EP - 255

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 4

ER -